Ann Kinga Malinowski

Dr. Ann Kinga Malinowski

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2008 in American Heart Journal
Verified
Journal Article
Closed access
SMSarah D. McDonald
Sarah D. McDonald
AMAnn Kinga Malinowski
Ann Kinga Malinowski
QZQi Zhou
Qi Zhou
SYSalim Yusuf
Salim Yusuf
PDPhilip J Devereaux
Philip J Devereaux

19 November 2015 in Blood
Verified
Journal Article
Closed access
PDF file
AMAnn Kinga Malinowski
Ann Kinga Malinowski
NSNadine Shehata
Nadine Shehata
RDRohan D'Souza
Rohan D'Souza
KKKevin H.M. Kuo
Kevin H.M. Kuo
RWRichard Ward
Richard Ward
KMKellie Murphy
Kellie Murphy
Key Points: Prophylactic transfusion in pregnant women with SCD may reduce maternal mortality, vaso-occlusive pain events, and pulmonary complications. Prophylactic transfusion in pregnant women with SCD may similarly reduce perinatal mortality, neonatal death, and preterm birth.

8 September 2016 in Blood
Verified
Journal Article
Closed access
PDF file
DSDongmei Sun
Dongmei Sun
NSNadine Shehata
Nadine Shehata
XYXiang Y. Ye
Xiang Y. Ye
SGSandra Gregorovich
Sandra Gregorovich
BFBryon De France
Bryon De France
AMAnn Kinga Malinowski
Ann Kinga Malinowski
Treatment options for immune thrombocytopenia (ITP) in pregnancy are limited, and evidence to guide management decisions is lacking. This retrospective study of singleton pregnancies from 2 tertiary centers compared the effectiveness of intravenous immunoglobulin (IVIg) and corticosteroids in treatment of ITP. Data from 195 women who had 235 pregnancies were reviewed. Treatment was not required in 137 pregnancies (58%). Of the remaining 98 pregnancies in 91 women, 47 (48%) were treated with IVIg and 51 were treated with corticosteroids as the initial intervention. Mean maternal platelet count at birth did not differ between groups (IVIg 69 × 109/L vs corticosteroids 77 × 109/L; P = .71) nor did the proportion of mothers who achieved a platelet count response (IVIg 38% vs corticosteroids 39%; P = .85). There were no fatal or severe maternal, fetal, or neonatal hemorrhages. Of 203 neonates in whom platelet counts were available, 56 (28%) had a birth platelet count <150 × 109/L and 18 (9%) had platelet counts <50 × 109/L. Nadir platelet counts for most affected neonates occurred at birth, although for some neonates, nadir platelet counts occurred up to 6 days postnatally. Intracranial hemorrhage was noted in 2 neonates (nadir platelet counts were 135 and 18 × 109/L). There were no neonatal deaths. The majority of pregnant women with a history of ITP did not require treatment, and neonatal outcomes were comparable for mothers who received IVIg or corticosteroids for treatment of maternal ITP. Key Points Maternal platelet count response was not different for IVIg and corticosteroids in this retrospective study of pregnant women with ITP. Neonatal outcomes were overall favorable and similar after treatment of maternal ITP with IVIg or corticosteroids.

1 December 2006 in Fertility and Sterility
Verified
Journal Article
Closed access
AMAnn Kinga Malinowski
Ann Kinga Malinowski
SBS.K. Bates
S.K. Bates

26 August 2020 in Journal of Thrombosis and Haemostasis
Verified
Journal Article
Closed access
PDF file
RKRezan Abdul Kadir
Rezan Abdul Kadir
TKTakao Kobayashi
Takao Kobayashi
Toshiaki IbaToshiaki Iba
Toshiaki Iba
OEOffer Erez
Offer Erez
JTJecko Thachil
Jecko Thachil
Maha OthmanMaha Othman
Maha Othman

4 September 2002 in Journal of Advanced Nursing
Verified
Journal Article
Closed access
PDF file
AMAnn Kinga Malinowski
Ann Kinga Malinowski
LSLynnette Leeseberg Stamler
Lynnette Leeseberg Stamler